When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MNLO - Menlo combo skin foam shows positive action in mid-stage acne study
VYNE Therapeutics
Menlo Therapeutics (MNLO-4.4%) announces positive, though mixed, results from a 447-subject Phase 2 clinical trial, Study FX2016-40, evaluating FCD105 (3% minocycline/0.3% adapalene foam) for the treatment of moderate-to-severe acne vulgaris.
More news on: Menlo Therapeutics Inc., Healthcare stocks news, Stocks on the move,